We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADAL
251
DELISTED
Anthemis Digital Acquisitions I Corp Class A Ordinary Shares
ADAL
$1.5M 0.04%
145,763
+71,932
+97% +$731K
HWH icon
252
HWH International
HWH
$11M
$1.5M 0.04%
29,842
-1,574
-5% -$78.1K
SDA icon
253
SunCar Technology Group
SDA
$77.2M
$1.48M 0.04%
144,116
-83,091
-37% -$858K
GRML
254
Greenland Mines Ltd
GRML
$29.2M
$1.44M 0.04%
142,914
+1
+0% +$10
TWLV
255
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
$1.41M 0.04%
140,702
-384,312
-73% -$3.82M
GMFI
256
DELISTED
Aetherium Acquisition Corp
GMFI
$1.35M 0.03%
133,012
-27,769
-17% -$279K
SHUA
257
DELISTED
SHUAA Partners Acquisition Corp I Class A Ordinary Share
SHUA
$1.34M 0.03%
129,851
+77,033
+146% +$787K
DTI icon
258
Drilling Tools International
DTI
$82.6M
$1.32M 0.03%
129,420
+36,962
+40% +$374K
ABP
259
DELISTED
Abpro Holdings
ABP
$1.3M 0.03%
4,256
-2,500
-37% -$757K
ACAC
260
DELISTED
Acri Capital Acquisition Corp
ACAC
$1.27M 0.03%
123,883
-612,478
-83% -$6.23M
LGVC
261
DELISTED
LAMF Global Ventures Corp. I Class A Ordinary Shares
LGVC
$1.26M 0.03%
123,326
+87,139
+241% +$886K
FPAC
262
DELISTED
Far Peak Acquisition Corporation
FPAC
$1.25M 0.03%
124,700
-139,906
-53% -$1.39M
CHEA
263
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
$1.23M 0.03%
119,707
+78,017
+187% +$796K
SCOBU
264
DELISTED
ScION Tech Growth II Units
SCOBU
$1.23M 0.03%
121,867
+121,612
+47,691% +$1.22M
FICV
265
DELISTED
Frontier Investment Corp Class A Ordinary Shares
FICV
$1.22M 0.03%
121,411
+35,831
+42% +$356K
HMA
266
DELISTED
Heartland Media Acquisition Corp.
HMA
$1.21M 0.03%
+118,761
New +$1.2M
DTRT
267
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
$1.2M 0.03%
115,802
-68,819
-37% -$705K
PPYA
268
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
$1.16M 0.03%
113,892
-86,628
-43% -$875K
FSRX
269
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$1.16M 0.03%
115,160
-222,978
-66% -$2.22M
DMYS
270
DELISTED
dMY Technology Group, Inc. VI
DMYS
$1.15M 0.03%
+114,830
New +$1.14M
FINMU
271
DELISTED
Marlin Technology Corporation Unit
FINMU
$1.15M 0.03%
116,153
+106,923
+1,158% +$1.07M
CFFS
272
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
$1.14M 0.03%
111,657
-13,728
-11% -$138K
WTMA
273
DELISTED
Welsbach Technology Metals Acquisition Corp. Common Stock
WTMA
$1.11M 0.03%
109,349
+16,461
+18% +$166K
SOC icon
274
Sable Offshore Corp
SOC
$1.01B
$1.09M 0.03%
108,892
+96,612
+787% +$964K
GSD
275
DELISTED
Global Systems Dynamics Inc. Class A Common Stock
GSD
$1.07M 0.03%
+103,621
New +$1.06M

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.